Heartflow

The Largest Prospective Registry on Plaque Analysis in Coronary Artery Disease

CCTA + Heartflow assesses blood flow across the coronary arteries to determine the need for revascularization.

Heartflow provides medical education on coronary artery disease diagnostics, including the role of CCTA and Heartflow, through on-demand resources, faculty-led programs, and continuing education.

Heartflow offers resources to help healthcare providers promote the CCTA + Heartflow pathway in their communities.

Heartflow is a medical technology company transforming the way coronary artery disease (CAD) is diagnosed, treated and managed.

Heartflow advances coronary care by empowering clinicians with precision tools and insights to optimize care delivery and achieve the best possible outcomes.

Heartflow is committed to achieving net zero emissions by 2045.

Heartflow requires transparency in its business and supply chains, expecting suppliers, contractors, and partners to meet the same standards.

Heartflow provides customer and product support, as well as handling inquiries for press, investors, and general topics.

Heartflow lists locations where users can receive a Heartflow Analysis, with additional support available via email or phone.

Apply here to participate in the Heartflow Research Grant Program.

Heartflow Support specialists assist teams in optimizing CCTA and coronary programs to improve efficiency and patient reach.

Heartflow’s vision is to transform CAD from the leading cause of death into a disease that can be managed for life.

This policy outlines how Heartflow collects, uses, and protects user information on its website.

GitHubRepository owner